Zymeworks Expands Board with Financial Veterans Greg Ciongoli and Robert E. Landry
VANCOUVER, British Columbia – August 11, 2025 Clinical-stage biotechnology firm Zymeworks Inc. (Nasdaq: ZYME) has strengthened its governance and strategic oversight by appointing Greg Ciongoli and Robert E. Landry to…






